An Expert’s Guide to SABCS 2024: A Preview of the Top Abstracts

Content Format:

Conference Coverage

Credit Type:

--

Credits:

--
Conversaciones sobre el cáncer de mama RH positivo/HER2 negativo en el panorama terapéutico en expansión de los inhibidores de CDK4/6

Content Format:

PDF

Credit Type:

--

Credits:

--
Especialistas respondem às suas perguntas sobre inibidores de CDK4/6 no câncer de mama HR+/HER2-

Content Format:

PDF

Credit Type:

--

Credits:

--
Conversas sobre o câncer: o cenário terapêutico em expansão para inibidores de CDK4/6 em câncer de mama HR-positivo/HER2-negativo

Content Format:

PDF

Credit Type:

--

Credits:

--
Des experts répondent à vos questions concernant les inhibiteurs de CDK4/6 dans le cancer du sein HR+/HER2-

Content Format:

PDF

Credit Type:

--

Credits:

--
Conversations autour du cancer portant sur l'élargissement du paysage thérapeutique des inhibiteurs de CDK4/6 dans le traitement du cancer du sein HR+/HER2-

Content Format:

PDF

Credit Type:

--

Credits:

--
InterACT Oncology Team Training: Improving Clinical Outcomes for Patients With High-Risk HR-Positive/HER2-Negative Early-Stage Breast Cancer

Content Format:

Slideset

Credit Type:

--

Credits:

--
Experts Discuss the Role of CDK4/6 Inhibitors in HR+/HER2- Breast Cancer

Content Format:

Podcast Episodes

Credit Type:

ABIM MOC | AMA

Credits:

0.50
Experts Answer Your Questions on CDK4/6 Inhibitors in HR+/HER2- Breast Cancer

Content Format:

Clinical Thought

Credit Type:

ABIM MOC | AMA

Credits:

0.25
Cancer Conversations on the Expanding Therapeutic Landscape for CDK4/6 Inhibitors in HR-Positive/HER2-Negative Breast Cancer

Content Format:

Video

Credit Type:

ABIM MOC | AMA

Credits:

1.50
Cancer Conversations on the Expanding Therapeutic Landscape for CDK4/6 Inhibitors in HR-Positive/HER2-Negative Breast Cancer

Content Format:

Slideset

Credit Type:

ABIM MOC | AMA

Credits:

1.00
Improving Outcomes in Patients With High-Risk Breast Cancer: Expert Guidance and Team Training for HR-Positive/HER2-Negative Disease

Content Format:

Text Module

Credit Type:

AAPA | ACPE | AMA | ANCC

Credits:

1.00
Advances in CDK4/6 Inhibition in EBC: Expert Guidance and Case Challenges for the Multidisciplinary Team

Content Format:

Video

Credit Type:

AAPA | ACPE | AMA | ANCC

Credits:

1.00
Highlights From the 2023 San Antonio Breast Cancer Symposium

Content Format:

Text Module

Credit Type:

AAPA | ACPE | AMA | ANCC

Credits:

1.25
Advances in CDK4/6 Inhibition in EBC: Expert Guidance and Case Challenges for the Multidisciplinary Team

Content Format:

Slideset

Credit Type:

--

Credits:

--
Key Studies in Breast, Lung, Gastrointestinal, Genitourinary, and Skin Cancers: CCO Independent Conference Highlights of the 2023 ESMO Congress

Content Format:

Conference Coverage

Credit Type:

AAPA | ACPE | AMA | ANCC

Credits:

1.50
HR-Positive/HER2-Negative Breast Cancer: Patient–Provider Communication Checklist

Content Format:

PDF

Credit Type:

--

Credits:

--
How I Manage Key Toxicities With Adjuvant CDK4/6 Inhibitors for Early Breast Cancer

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Educational Opportunities to Improve Community Healthcare Professionals’ Management of High-Risk HR-Positive/HER2-Negative Early Breast Cancer

Content Format:

PDF

Credit Type:

--

Credits:

--
An Expert’s Guide to SABCS 2023: A Preview of the Top Abstracts

Content Format:

Conference Coverage

Credit Type:

--

Credits:

--
Applying the Latest Developments in Metastatic Breast Cancer Through Education of Healthcare Professionals, Patients, and Caregivers

Content Format:

Text Module

Credit Type:

ACPE | AMA | ANCC

Credits:

1.50
Metastatic Breast Cancer: Patient-Provider Communication Checklist

Content Format:

PDF

Credit Type:

--

Credits:

--
An Expert’s Guide to ESMO 2023: A Preview of the Top Abstracts

Content Format:

Conference Coverage

Credit Type:

--

Credits:

--
Applying the Latest Developments in Metastatic Breast Cancer Through Education of Healthcare Professionals, Patients, and Caregivers

Content Format:

Slideset

Credit Type:

--

Credits:

--
Targeting AKT in Breast Cancer: Emerging Therapies

Content Format:

Video

Credit Type:

--

Credits:

--
Metastatic Breast Cancer: Patient-Provider Communication Checklist

Content Format:

PDF

Credit Type:

--

Credits:

--
Key Decision Points in Neoadjuvant and Adjuvant Treatment Selection for Early-Stage HER2-Negative Breast Cancer

Content Format:

PDF

Credit Type:

--

Credits:

--
My Thoughts on the Potential of AKT Inhibitors in Metastatic Breast Cancer

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Targeting AKT in HER2-Negative Breast Cancer: Implications for Future Clinical Practice

Content Format:

Slideset

Credit Type:

--

Credits:

--
Targeting AKT in HER2-Negative Breast Cancer: Implications for Future Clinical Practice

Content Format:

Text Module

Credit Type:

AMA

Credits:

1.00
The Evolving Treatment of Early Breast Cancer: Expert Answers to FAQs

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Evening With the Experts: Discussing the Rapidly Evolving Treatment Landscape for Early-Stage Breast Cancer

Content Format:

Video

Credit Type:

AMA

Credits:

1.50
The New Treatment Paradigm and Ongoing Questions for Early-Stage TNBC

Content Format:

Slideset

Credit Type:

--

Credits:

--
Highlights From the 2022 San Antonio Breast Cancer Symposium

Content Format:

Conference Coverage

Credit Type:

AMA

Credits:

1.00
Improving Outcomes for Patients With High-Risk, HR-Positive/HER2-Negative Early Breast Cancer: Education and Resources for the Multidisciplinary Team

Content Format:

Video

Credit Type:

ACPE | AMA | ANCC with Pharmacotherapy Credit

Credits:

1.00
Expert Answers to FAQ on Neo/Adjuvant Therapy in Early Breast Cancer

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
A Look Ahead to SABCS 2022

Content Format:

Conference Coverage

Credit Type:

--

Credits:

--
How Risk of Recurrence in HR-Positive/HER2-Negative Early Breast Cancer Impacts Therapeutic Choices

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Key Studies in Breast and Gynecologic Cancers: Independent Conference Coverage of the 2022 ASCO Annual Meeting

Content Format:

Conference Coverage

Credit Type:

AMA

Credits:

1.50
An Interactive Tool for Managing AEs With Oral Targeted Therapies for HR+, HER2– Breast Cancer

Content Format:

Tool

Credit Type:

--

Credits:

--